July 9, 2026 12:35

Arterex, the contract manufacturing platform for plastic medical products created by Italian investment company Investindustrial, has announced the acquisition of Eurostamp, a Novi di Modena-based company in northern Italy specialising in the design and manufacture of injection molds.

Founded in 1989 by Claudio Zenoni and Fausto Lugli, Eurostamp supplies molds for applications in the medical, packaging and cosmetics sectors, managing the entire production cycle in-house, from design to manufacture and testing. According to the buyer, the two founders will remain at the helm of the company to ensure operational continuity.

The addition of Eurostamp further broadens Arterex’s industrial scope, which now covers mold building, extrusion, injection molding, blow molding, compounding and assembly.

“Eurostamp is exactly the kind of company we look for when expanding the Arterex platform, with deep expertise, a proven track record, and a team that is passionate about delivering for customers,” said Jeff Goble, President & CEO, Arterex. “This acquisition strengthens our European capabilities in a meaningful way and gives our customers access to world-class tooling and mold-building expertise as part of a truly integrated manufacturing partner.”

Arterex was established in 2022 through the combination of four companies: US-based Formula Plastics and Italian companies Kabo, Luc & Bel and ModenPlast. A year later, it acquired North America’s NextPhase and, in 2024, expanded with the addition of Micromold, followed by the recent acquisitions of Phoenix, Adroit, Xponent Global, Synecco and, most recently, Eurostamp. The group now operates 16 facilities in the United States, Mexico, Egypt, India, Ireland and Italy, with more than 2,300 employees. Its contract manufacturing activities focus on Class I, II and III medical devices.

© Polimerica -  Reproduction prohibited, all rights reserved